These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36547597)

  • 1. A Regional Observational Study on COVID-19-Associated Pulmonary Aspergillosis (CAPA) within Intensive Care Unit: Trying to Break the Mold.
    Lupia T; Montrucchio G; Gaviraghi A; Musso G; Puppo M; Bolla C; Shbaklo N; Rizzello B; Della Selva A; Concialdi E; Rumbolo F; Barbui AM; Brazzi L; De Rosa FG; Corcione S
    J Fungi (Basel); 2022 Nov; 8(12):. PubMed ID: 36547597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Aspergillosis in Critically Ill COVID-19 Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study.
    Bergmann F; Jorda A; Blaschke A; Gabler C; Bohdan S; Nussbaumer-Pröll A; Radtke C; Zeitlinger M
    J Fungi (Basel); 2023 Mar; 9(3):. PubMed ID: 36983483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave.
    Bretagne S; Sitbon K; Botterel F; Dellière S; Letscher-Bru V; Chouaki T; Bellanger AP; Bonnal C; Fekkar A; Persat F; Costa D; Bourgeois N; Dalle F; Lussac-Sorton F; Paugam A; Cassaing S; Hasseine L; Huguenin A; Guennouni N; Mazars E; Le Gal S; Sasso M; Brun S; Cadot L; Cassagne C; Cateau E; Gangneux JP; Moniot M; Roux AL; Tournus C; Desbois-Nogard N; Le Coustumier A; Moquet O; Alanio A; Dromer F;
    Microbiol Spectr; 2021 Oct; 9(2):e0113821. PubMed ID: 34668768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review.
    Chong WH; Neu KP
    J Hosp Infect; 2021 Jul; 113():115-129. PubMed ID: 33891985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Risk Factors of COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit-A Monocentric Retrospective Observational Study.
    Gregoire E; Pirotte BF; Moerman F; Altdorfer A; Gaspard L; Firre E; Moonen M; Fraipont V; Ernst M; Darcis G
    Pathogens; 2021 Oct; 10(11):. PubMed ID: 34832526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
    Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
    Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective, observational study.
    Feys S; Vanmassenhove S; Kraisin S; Yu K; Jacobs C; Boeckx B; Cambier S; Cunha C; Debaveye Y; Gonçalves SM; Hermans G; Humblet-Baron S; Jansen S; Lagrou K; Meersseman P; Neyts J; Peetermans M; Rocha-Pereira J; Schepers R; Spalart V; Starick MR; Thevissen K; Van Brussel T; Van Buyten T; Van Mol P; Vandenbriele C; Vanderbeke L; Wauters E; Wilmer A; Van Weyenbergh J; Van De Veerdonk FL; Carvalho A; Proost P; Martinod K; Lambrechts D; Wauters J
    Lancet Microbe; 2024 Mar; 5(3):e247-e260. PubMed ID: 38280387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate microbiological examinations are crucial for the timely diagnosis of CAPA.
    Zhou X; Wu X; Chen Z; Cui X; Cai Y; Liu Y; Weng B; Zhan Q; Huang L
    Front Cell Infect Microbiol; 2023; 13():1287496. PubMed ID: 38076456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation.
    Feys S; Lagrou K; Lauwers HM; Haenen K; Jacobs C; Brusselmans M; Debaveye Y; Hermans G; Hoenigl M; Maertens J; Meersseman P; Peetermans M; Spriet I; Vandenbriele C; Vanderbeke L; Vos R; Van Wijngaerden E; Wilmer A; Wauters J
    Clin Infect Dis; 2024 Feb; 78(2):361-370. PubMed ID: 37691392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a
    Giacobbe DR; Prattes J; Wauters J; Dettori S; Signori A; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Klimko N; Shadrivova O; Cornely OA; Rautemaa-Richardson R; Koehler P; Lagrou K; Bassetti M; Hoenigl M;
    J Clin Microbiol; 2022 Apr; 60(4):e0229821. PubMed ID: 35321555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity.
    Machado M; Valerio M; Álvarez-Uría A; Olmedo M; Veintimilla C; Padilla B; De la Villa S; Guinea J; Escribano P; Ruiz-Serrano MJ; Reigadas E; Alonso R; Guerrero JE; Hortal J; Bouza E; Muñoz P;
    Mycoses; 2021 Feb; 64(2):132-143. PubMed ID: 33210776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave.
    Bentvelsen RG; Arkel ALEV; Rijpstra TA; Kant MKM; Brugge SVS; Loth DW; Van Wijngaarden P; Mée AWFD; Yick DCY; Diederen BMW; Wever PC; Leenders ACAP; Van Dommelen L; Groot KH; Van den Bijllaardt W; Verweij PE
    J Fungi (Basel); 2022 Jan; 8(2):. PubMed ID: 35205851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19-Associated Pulmonary Aspergillosis (CAPA).
    Dimopoulos G; Almyroudi MP; Myrianthefs P; Rello J
    J Intensive Med; 2021 Oct; 1(2):71-80. PubMed ID: 36785564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19-associated pulmonary aspergillosis in patients with severe SARS-CoV-2 infection: A single-center observational study from Greece.
    Ouranos K; Tsakiri K; Massa E; Dourliou V; Mouratidou C; Soundoulounaki S; Mouloudi E
    Ann Thorac Med; 2023; 18(3):116-123. PubMed ID: 37663880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.
    Bartoletti M; Pascale R; Cricca M; Rinaldi M; Maccaro A; Bussini L; Fornaro G; Tonetti T; Pizzilli G; Francalanci E; Giuntoli L; Rubin A; Moroni A; Ambretti S; Trapani F; Vatamanu O; Ranieri VM; Castelli A; Baiocchi M; Lewis R; Giannella M; Viale P;
    Clin Infect Dis; 2021 Dec; 73(11):e3606-e3614. PubMed ID: 32719848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study.
    Hatzl S; Reisinger AC; Posch F; Prattes J; Stradner M; Pilz S; Eller P; Schoerghuber M; Toller W; Gorkiewicz G; Metnitz P; Rief M; Prüller F; Rosenkranz AR; Valentin T; Krause R; Hoenigl M; Schilcher G
    Crit Care; 2021 Sep; 25(1):335. PubMed ID: 34526087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina.
    Giusiano G; Fernández NB; Vitale RG; Alvarez C; Ochiuzzi ME; Santiso G; Cabeza MS; Tracogna F; Farías L; Afeltra J; Noblega LM; Giuliano CV; Garcia-Effron G
    Med Mycol; 2022 May; 60(5):. PubMed ID: 35394043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of Aspergillus spp. isolation in defining cases of COVID-19 Associated Pulmonary Aspergillosis - CAPA.
    Cocio TA; Siqueira LPM; Riciluca KCT; Gimenes VMF; de Andrade TS; Benard G; Martínez R; Bollela VR
    Braz J Infect Dis; 2023; 27(4):102793. PubMed ID: 37507102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy.
    van Grootveld R; van der Beek MT; Janssen NAF; Ergün M; van Dijk K; Bethlehem C; Stads S; van Paassen J; Heunks LMA; Bouman CSC; Reijers MHE; Brüggeman RJ; van de Veerdonk FL; van Bree SHW; van den Berg CHSB; Kuindersma M; Wauters J; Beishuizen A; Verweij PE; Schouten JA;
    J Crit Care; 2023 Aug; 76():154272. PubMed ID: 36801598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19-Associated Invasive Pulmonary Aspergillosis in the Intensive Care Unit: A Case Series in a Portuguese Hospital.
    Ranhel D; Ribeiro A; Batista J; Pessanha M; Cristovam E; Duarte A; Dias A; Coelho L; Monteiro F; Freire P; Veríssimo C; Sabino R; Toscano C
    J Fungi (Basel); 2021 Oct; 7(10):. PubMed ID: 34682302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.